These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29094222)

  • 1. Restorative Strategies in Movement Disorders: the Contribution of Imaging.
    Lao-Kaim NP; Piccini P; Tai YF
    Curr Neurol Neurosci Rep; 2017 Nov; 17(12):98. PubMed ID: 29094222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Transplantation in Movement Disorders.
    de Natale ER; Wilson H; Pagano G; Politis M
    Int Rev Neurobiol; 2018; 143():213-263. PubMed ID: 30473196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders.
    Peralta C; Biafore F; Depetris TS; Bastianello M
    Curr Neurol Neurosci Rep; 2019 Jun; 19(8):56. PubMed ID: 31256288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography imaging of transplant function.
    Brooks DJ
    NeuroRx; 2004 Oct; 1(4):482-91. PubMed ID: 15717049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restorative neurology in movement disorders.
    Hagell P
    J Neurosci Nurs; 2000 Oct; 32(5):256-62. PubMed ID: 11089197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegenerative movement disorders: the contribution of functional imaging.
    Piccini P
    Curr Opin Neurol; 2004 Aug; 17(4):459-66. PubMed ID: 15247543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of positron emission tomography imaging in movement disorders.
    Bohnen NI; Frey KA
    Neuroimaging Clin N Am; 2003 Nov; 13(4):791-803. PubMed ID: 15024962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging and therapeutics in movement disorders.
    Eckert T; Eidelberg D
    NeuroRx; 2005 Apr; 2(2):361-71. PubMed ID: 15897956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of dopamine in positive and negative prediction error utilization during incidental learning - Insights from Positron Emission Tomography, Parkinson's disease and Huntington's disease.
    Mathar D; Wilkinson L; Holl AK; Neumann J; Deserno L; Villringer A; Jahanshahi M; Horstmann A
    Cortex; 2017 May; 90():149-162. PubMed ID: 27751503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.
    Kordower JH; Freeman TB; Snow BJ; Vingerhoets FJ; Mufson EJ; Sanberg PR; Hauser RA; Smith DA; Nauert GM; Perl DP
    N Engl J Med; 1995 Apr; 332(17):1118-24. PubMed ID: 7700284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography in movement disorders.
    Martin WR
    Can J Neurol Sci; 1985 Feb; 12(1):6-10. PubMed ID: 3156662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of movement disorders studied using PET.
    Leenders KL
    J Neural Transm Suppl; 1997; 50():39-46. PubMed ID: 9120423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging in Parkinson's disease: the role of monoamines in behavior.
    Brooks DJ; Piccini P
    Biol Psychiatry; 2006 May; 59(10):908-18. PubMed ID: 16581032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease.
    Pirker W; Asenbaum S; Wenger S; Kornhuber J; Angelberger P; Deecke L; Podreka I; Brücke T
    J Nucl Med; 1997 Nov; 38(11):1711-7. PubMed ID: 9374338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography and central neurotransmitter systems in movement disorders.
    Weeks RA; Brooks DJ
    Fundam Clin Pharmacol; 1994; 8(6):503-17. PubMed ID: 7721227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET Imaging in Huntington's Disease.
    Roussakis AA; Piccini P
    J Huntingtons Dis; 2015; 4(4):287-96. PubMed ID: 26683130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET Imaging of Serotonin Transporters With 4-[(18)F]-ADAM in a Parkinsonian Rat Model With Porcine Neural Xenografts.
    Chiu CH; Li IH; Weng SJ; Huang YS; Wu SC; Chou TK; Huang WS; Liao MH; Shiue CY; Cheng CY; Ma KH
    Cell Transplant; 2016; 25(2):301-11. PubMed ID: 25994923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dementia in movement disorders.
    Teräväinen H; Hietanen M; Stoessl J; Calne DB
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):546-58. PubMed ID: 2947669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET and movement disorders.
    Brooks DJ; Frackowiak RS
    J Neurol Neurosurg Psychiatry; 1989 Jun; Suppl(Suppl):68-77. PubMed ID: 2666580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography after fetal transplantation in Huntington's disease.
    Furtado S; Sossi V; Hauser RA; Samii A; Schulzer M; Murphy CB; Freeman TB; Stoessl AJ
    Ann Neurol; 2005 Aug; 58(2):331-7. PubMed ID: 16049929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.